Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110-Reference-Cited by-同舟云学术

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

Published:2019-12-01 Issue:4 Volume:82 Page:392-398
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Clarke Diana F.,Mirochnick Mark,Acosta Edward P.,Capparelli Edmund,Chain Anne,Teppler Hedy,Smith Betsy,Lommerse Jos,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference16 articles.

1. Raltegravir pharmacokinetics in neonates following maternal dosing;Clarke;J Acquir Immune Defic Syndr.,2014

2. The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver;Kawade;Biochem J.,1981

3. Ontogeny of hepatic glucuronidation; methods and results;Krekels;Curr Drug Metab.,2012

4. Raltegravir in vitro effect on bilirubin binding;Clarke;Pediatr Infect Dis J.,2013

5. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens;Andersen;Pediatrics.,1956

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human immunodeficiency virus/acquired immunodeficiency syndrome in the infant;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Virtual Tools and Screening Designs for Drug Discovery and New Drug Development;Software and Programming Tools in Pharmaceutical Research;2024-03-19

3. Updates in the Approach to Pediatric HIV Care and Prevention;Current Treatment Options in Pediatrics;2023-10-13

4. Pediatric AIDS–Therapeutic Successes Built on a Foundation of Pediatric Clinical Pharmacology with Pharmacokinetic-Pharmacodynamic Modeling;The Journal of Pediatric Pharmacology and Therapeutics;2022-07-01

5. Optimizing Dolutegravir Initiation in Neonates Using Population Pharmacokinetic Modeling and Simulation;JAIDS Journal of Acquired Immune Deficiency Syndromes;2022-01-01